LQT Therapeutics
LQT Therapeutics, Inc. is pioneering a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias based on research from Beth Israel Deacons Medical Center, Massachusetts General Hospital, and Sanofi, S.A. By combining leading-edge cardiovascular genetics and diagnostics with recent advances in the understanding of the role of SGK1, LQT Therapeutics seeks to make a meaningful difference in the lives of people suffering from Long QT Syndrome and resistant cancers. Launched in 2019. LQT Therapeutics was founded by world-class experts in cardiovascular disease, cardiac muscle biology and drug development.
lqttrx.comLaval, QC, Canada
Inaccurate data? Flag it here.Open jobs at LQT Therapeutics